EPS Becomes First Domestic CRO to Obtain 'myMedidata eCOA Accreditation'
Key facts
- EPS Becomes First Domestic CRO to Obtain 'myMedidata eCOA Accreditation'
- EPS has obtained certification to build Medidata's eCOA solutions, potentially reducing trial setup time to as little as two months.
- Source: PR Times
- Date: June 10, 2026
Direct answer
EPS has obtained certification to build Medidata's eCOA solutions, potentially reducing trial setup time to as little as two months.
- Citation
- EPS Becomes First Domestic CRO to Obtain 'myMedidata eCOA Accreditation' (June 10, 2026), PR Times
- Source
- PR Times
- Date
- June 10, 2026
EPS has obtained certification to build Medidata's eCOA solutions, potentially reducing trial setup time to as little as two months.
📋 Article Processing Timeline
- 📰 Published: June 10, 2026 at 14:00
- 🔍 Collected: June 10, 2026 at 14:23 (23 min after Published)
- 🤖 AI Analyzed: June 11, 2026 at 00:19 (9h 56m after Collected)
By obtaining this accreditation, EPS is now equipped to build and manage eCOA solutions in-house. This allows EPS to shorten the standard four-month setup timeline for EDC and eCOA to as little as two months, optimizing costs and facilitating rapid clinical trial initiation. Both companies aim to strengthen their collaboration to improve patient experience.
FAQ
What is the 'myMedidata eCOA Accreditation' qualification?
It is a certification from Medidata's official accreditation program to acquire specialized knowledge for building and managing eCOA solutions in-house.
What are the benefits for EPS in obtaining this qualification?
It enables an in-house setup for eCOA, speeding up trial configuration (from 4 months to as short as 2 months) and optimizing costs.
What are the features of Medidata's eCOA solution?
Through the patient portal 'myMedidata', it allows for the verification and signing of consent forms, diary entries, and online consultations with doctors.
How will this partnership impact clinical trials in Japan?
It will enable optimized support for the Japanese market and faster trial setup, improving the efficiency of clinical trials and patient experience.
What kind of company is Medidata?
Medidata is a leading provider of clinical trial solutions for the life sciences industry and is a subsidiary of Dassault Systèmes.